Clinical Study on the Effect of Tizanidine on the Function and Pain of Patients After Shoulder Arthroscopy

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study ID
NCT05852093
Phase
EARLY_PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Rotator Cuff Tears

Eligibility Criteria

Sex
ALL
Age
20 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Celecoxib+Buprenorphine Transdermal Patch — DRUG
    NSAIDs+narcotic analgesics
  • Celecoxib+Buprenorphine Transdermal Patch+Tizanidine — DRUG
    NSAIDs+narcotic analgesics+Skeletal Muscle Relaxant

Study Details

The perspective, randomized controlled trial is to investigate and evaluate the effect of Tizanidine on the function and pain of patients with rotator cuff tear after shoulder arthroscopy;

Key Dates

First listed
May 10, 2023
Start date
Jun 1, 2023
Status verified
May 2023
Primary completion
Jun 1, 2026
Completion
Jun 1, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Drug: Celecoxib+Buprenorphine Transdermal Patch
  • Experimental: Drug: Celecoxib+Buprenorphine Transdermal Patch+Tizanidine

Primary Outcome Measure

Pittsburgh sleep quality index；PSQI [ Time Frame: From Week 0 (baseline) to Week24 ]

Central Contacts

Related Studies